New iron drug CTX001 put to the test in healthy volunteers
NCT ID NCT07577817
First seen May 11, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This early-stage study tests an experimental drug called CTX001 in 72 healthy adults. The goal is to check for side effects, how the body processes the drug, and how it affects iron levels when taken with or without food and iron. No direct treatment benefit is expected; the study is purely for gathering safety and drug behavior information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.